Latest News & Updates

Breaking News

  • 9 hours ago

  • Team Pharma Now

Pharma Now Announces It's Webinar In Collaboration with Pharmig, to Inaugurate the Upcoming Pharmig India 2025 Summit
Breaking News
GRI Bio Releases 6-Week Interim Lung Function Results From Ongoing Phase 2a Clinical Study In Idiopathic Pulmonary Fibrosis (IPF)

Simantini Singh Deo

Other trending news you may like to read

Pharma Now Announces It's Webinar In Collaboration with Pharmig, to Inaugurate the Upcoming Pharmig India 2025 Summit

Pharma Now & Pharmig UK present a microbiology webinar on Annex 1, contamination control, and sterility assurance. Live on Sept 23, 2025.

Team Pharma Now

Pharma Now

GRI Bio Releases 6-Week Interim Lung Function Results From Ongoing Phase 2a Clinical Study In Idiopathic Pulmonary Fibrosis (IPF)

GRI Bio’s GRI-0621 shows no FVC decline and anti-fibrotic biomarker signals in Phase 2a IPF study six-week data.

Simantini Singh Deo

Pharma Now

OSE Immunotherapeutics & FoRT Foundation Complete Enrollment For Combi-TED Phase 2 Trial Testing Tedopi® With Nivolumab Or Docetaxel In Non-Small Cell Lung Cancer Patients

OSE Immunotherapeutics and FoRT complete enrollment in Combi-TED Phase 2 trial of Tedopi combos for metastatic NSCLC.

Simantini Singh Deo

Pharma Now

Immix Biopharma Appoints Renowned Biotech Leader And Former Tanox CEO Nancy T. Chang To Board of Directors Following Her Goose Capital Investment

Immix Biopharma adds biotech leader Nancy T. Chang to its Board, boosting strategy for advanced cell therapy programs.

Simantini Singh Deo

Pharma Now